Validity and Reliability of the Turkish Version of the Functional Shoulder Score

NCT ID: NCT03658707

Last Updated: 2022-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

116 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-23

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the validity and reliability of the Turkish version of the Functional Shoulder Score in Turkish patients with subacromial impingement syndrome (SIS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The original form of the Functional Shoulder Score will be translated into Turkish by two Turkish mother tongue translators who also speak English in advanced level. Then these translations will be combined into one translation and translated back to English. The pre-final version will be composed and tested on a group of patients with SIS. If necessary, readjustments will be made, and the validity of the final version will be investigated in 116 patients with SIS. Additionally, for the test-retest reliability, 59 patients will fill out the questionnaire again after 3-7 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subacromial Impingement Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire

Shoulder questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of subacromial impingement syndrome (Michener et al, 2009)
* To read and understand Turkish

Exclusion Criteria

* 50% limitation of passive shoulder range of motion in ≥ 2 planes of motion
* Glenohumeral instability
* Fracture or surgery history in the shoulder
* Another diagnosis that may affect shoulder function (frozen shoulder, primary shoulder arthritis, inflammatory/ neoplastic/neurological conditions, cervical spine induced pain)
* Systemic musculoskeletal disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dokuz Eylul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Damla Karabay

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sevgi Sevi YESILYAPRAK, PhD

Role: STUDY_DIRECTOR

Dokuz Eylul University

Halime Ezgi TURKSAN

Role: STUDY_CHAIR

Dokuz Eylul University

Mehmet ERDURAN, MD

Role: STUDY_CHAIR

Dokuz Eylul University

Damla KARABAY, MSc

Role: PRINCIPAL_INVESTIGATOR

Izmir Katip Celebi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dokuz Eylul University, School of Physical Therapy and Rehabilitation

Izmir, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Damla KARABAY

Role: CONTACT

2323293535 ext. +90

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Damla KARABAY, MS

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3864-GOA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.